MRSA on the Appalachian Trail: The Story of Steve Weisel

MRSA on the Appalachian Trail: The Story of Steve Weisel

Hiking the Appalachian Trail, Steve Weisel thought little of the blisters on his feet until he discovered they were infected with life-threatening methicillin-resistant Staphylococcus aureus (MRSA)—an increasingly common "superbug" that does not respond to first-line antibiotics. Mr. Weisel's story demonstrates the urgent need for new and innovative therapies to treat this growing threat.

Sixty-two years old and very active, Steve Weisel was about 300 miles into a long trek across the Appalachian Trail when blisters on his feet became too painful to bear. He stopped the hike early and returned to his home in Virginia.

Over the next week, Mr. Weisel's blisters did not heal and he developed a fever. When his temperature spiked, he checked into the infectious diseases clinic at the National Naval Medical Center in Maryland. The blisters he thought were harmless turned out to be infected with the dangerous superbug MRSA, which had also spread to his lungs. As a result, he had developed pneumonia and a collection of pus-filled abscesses between his lungs and chest wall.

To thwart the MRSA infection that had permeated his lungs, Mr. Weisel required aggressive medical intervention during his 18-day hospital stay. He underwent a number of major surgical procedures to drain the abscesses, and he was treated with six different antibiotics. He left with home-administered intravenous vancomycin—a medication that produced a rash so large and unpleasant that he had to be switched to yet another drug.

Though patients typically contract MRSA in a health care setting, rates of community-acquired MRSA have grown rapidly over the past 10 yearsand are not showing signs of declining.1

Mr. Weisel's battle lasted for well over a month and required a lengthy hospitalization and treatment followed by an arduous rehabilitation.

Fortunately, he made a full recovery and completed his 2,000-mile hike. His story illustrates the growing need for new antibiotics that can fight infections quickly and effectively.

1 Centers for Disease Control and Prevention, “MRSA Statistics,” last updated April 8, 2011, www.cdc.gov/mrsa/statistics/index.html (accessed November 9, 2011).

Spotlight on Mental Health

Composite image of modern city network communication concept

Learn the Basics of Broadband from Our Limited Series

Sign up for our four-week email course on Broadband Basics

Quick View

How does broadband internet reach our homes, phones, and tablets? What kind of infrastructure connects us all together? What are the major barriers to broadband access for American communities?

Pills illustration
Pills illustration

What Is Antibiotic Resistance—and How Can We Fight It?

Sign up for our four-week email series The Race Against Resistance.

Quick View

Antibiotic-resistant bacteria, also known as “superbugs,” are a major threat to modern medicine. But how does resistance work, and what can we do to slow the spread? Read personal stories, expert accounts, and more for the answers to those questions in our four-week email series: Slowing Superbugs.

Explore Pew’s new and improved
Fiscal 50 interactive

Your state's stats are more accessible than ever with our new and improved Fiscal 50 interactive:

  • Maps, trends, and customizable charts
  • 50-state rankings
  • Analysis of what it all means
  • Shareable graphics and downloadable data
  • Proven fiscal policy strategies

Explore

Welcome to the new Fiscal 50

Key changes include:

  • State pages that help you keep track of trends in your home state and provide national and regional context.
  • Interactive indicator pages with highly customizable and shareable data visualizations.
  • A Budget Threads feature that offers Pew’s read on the latest state fiscal news.

Learn more about the new and improved Fiscal 50.